These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 32647865

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Protective Roles of Interferon-γ in Cardiac Hypertrophy Induced by Sustained Pressure Overload.
    Kimura A, Ishida Y, Furuta M, Nosaka M, Kuninaka Y, Taruya A, Mukaida N, Kondo T.
    J Am Heart Assoc; 2018 Mar 19; 7(6):. PubMed ID: 29555642
    [Abstract] [Full Text] [Related]

  • 3. Osteopontin RNA aptamer can prevent and reverse pressure overload-induced heart failure.
    Li J, Yousefi K, Ding W, Singh J, Shehadeh LA.
    Cardiovasc Res; 2017 May 01; 113(6):633-643. PubMed ID: 28453726
    [Abstract] [Full Text] [Related]

  • 4. A gene therapeutic approach to inhibit calcium and integrin binding protein 1 ameliorates maladaptive remodelling in pressure overload.
    Grund A, Szaroszyk M, Döppner JK, Malek Mohammadi M, Kattih B, Korf-Klingebiel M, Gigina A, Scherr M, Kensah G, Jara-Avaca M, Gruh I, Martin U, Wollert KC, Gohla A, Katus HA, Müller OJ, Bauersachs J, Heineke J.
    Cardiovasc Res; 2019 Jan 01; 115(1):71-82. PubMed ID: 29931050
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mechanosensitive Gene Regulation by Myocardin-Related Transcription Factors Is Required for Cardiomyocyte Integrity in Load-Induced Ventricular Hypertrophy.
    Trembley MA, Quijada P, Agullo-Pascual E, Tylock KM, Colpan M, Dirkx RA, Myers JR, Mickelsen DM, de Mesy Bentley K, Rothenberg E, Moravec CS, Alexis JD, Gregorio CC, Dirksen RT, Delmar M, Small EM.
    Circulation; 2018 Oct 23; 138(17):1864-1878. PubMed ID: 29716942
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload.
    Beetz N, Rommel C, Schnick T, Neumann E, Lother A, Monroy-Ordonez EB, Zeeb M, Preissl S, Gilsbach R, Melchior-Becker A, Rylski B, Stoll M, Schaefer L, Beyersdorf F, Stiller B, Hein L.
    J Mol Cell Cardiol; 2016 Dec 23; 101():145-155. PubMed ID: 27789290
    [Abstract] [Full Text] [Related]

  • 9. Substrain specific response to cardiac pressure overload in C57BL/6 mice.
    Garcia-Menendez L, Karamanlidis G, Kolwicz S, Tian R.
    Am J Physiol Heart Circ Physiol; 2013 Aug 01; 305(3):H397-402. PubMed ID: 23709599
    [Abstract] [Full Text] [Related]

  • 10. Lansoprazole alleviates pressure overload-induced cardiac hypertrophy and heart failure in mice by blocking the activation of β-catenin.
    Lin H, Li Y, Zhu H, Wang Q, Chen Z, Chen L, Zhu Y, Zheng C, Wang Y, Liao W, Bin J, Kitakaze M, Liao Y.
    Cardiovasc Res; 2020 Jan 01; 116(1):101-113. PubMed ID: 30689763
    [Abstract] [Full Text] [Related]

  • 11. Intercellular Adhesion Molecule 1 Regulates Left Ventricular Leukocyte Infiltration, Cardiac Remodeling, and Function in Pressure Overload-Induced Heart Failure.
    Salvador AM, Nevers T, Velázquez F, Aronovitz M, Wang B, Abadía Molina A, Jaffe IZ, Karas RH, Blanton RM, Alcaide P.
    J Am Heart Assoc; 2016 Mar 15; 5(3):e003126. PubMed ID: 27068635
    [Abstract] [Full Text] [Related]

  • 12. Preservation of Acyl Coenzyme A Attenuates Pathological and Metabolic Cardiac Remodeling Through Selective Lipid Trafficking.
    Goldenberg JR, Carley AN, Ji R, Zhang X, Fasano M, Schulze PC, Lewandowski ED.
    Circulation; 2019 Jun 11; 139(24):2765-2777. PubMed ID: 30909726
    [Abstract] [Full Text] [Related]

  • 13. In vivo cardiac role of migfilin during experimental pressure overload.
    Haubner BJ, Moik D, Schuetz T, Reiner MF, Voelkl JG, Streil K, Bader K, Zhao L, Scheu C, Mair J, Pachinger O, Metzler B.
    Cardiovasc Res; 2015 Jun 01; 106(3):398-407. PubMed ID: 25852081
    [Abstract] [Full Text] [Related]

  • 14. Ecto-5'-nucleotidase deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction.
    Xu X, Fassett J, Hu X, Zhu G, Lu Z, Li Y, Schnermann J, Bache RJ, Chen Y.
    Hypertension; 2008 Jun 01; 51(6):1557-64. PubMed ID: 18391093
    [Abstract] [Full Text] [Related]

  • 15. Mitochondrial Integrity and Function in the Progression of Early Pressure Overload-Induced Left Ventricular Remodeling.
    Chaanine AH, Sreekumaran Nair K, Bergen RH, Klaus K, Guenzel AJ, Hajjar RJ, Redfield MM.
    J Am Heart Assoc; 2017 Jun 15; 6(6):. PubMed ID: 28619984
    [Abstract] [Full Text] [Related]

  • 16. FABP5 Deficiency Impairs Mitochondrial Function and Aggravates Pathological Cardiac Remodeling and Dysfunction.
    Gao S, Li G, Shao Y, Wei Z, Huang S, Qi F, Jiao Y, Li Y, Zhang C, Du J.
    Cardiovasc Toxicol; 2021 Aug 15; 21(8):619-629. PubMed ID: 33929718
    [Abstract] [Full Text] [Related]

  • 17. The ATP-binding cassette transporter ABCG2 protects against pressure overload-induced cardiac hypertrophy and heart failure by promoting angiogenesis and antioxidant response.
    Higashikuni Y, Sainz J, Nakamura K, Takaoka M, Enomoto S, Iwata H, Tanaka K, Sahara M, Hirata Y, Nagai R, Sata M.
    Arterioscler Thromb Vasc Biol; 2012 Mar 15; 32(3):654-61. PubMed ID: 22116099
    [Abstract] [Full Text] [Related]

  • 18. Rats are protected from the stress of chronic pressure overload compared with mice.
    Nishimura K, Oydanich M, Zhang J, Babici D, Fraidenraich D, Vatner DE, Vatner SF.
    Am J Physiol Regul Integr Comp Physiol; 2020 May 01; 318(5):R894-R900. PubMed ID: 32209023
    [Abstract] [Full Text] [Related]

  • 19. The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload.
    Zhou N, Ma B, Stoll S, Hays TT, Qiu H.
    Aging Cell; 2017 Oct 01; 16(5):1168-1179. PubMed ID: 28799247
    [Abstract] [Full Text] [Related]

  • 20. Toll-like receptor-2 mediates adaptive cardiac hypertrophy in response to pressure overload through interleukin-1β upregulation via nuclear factor κB activation.
    Higashikuni Y, Tanaka K, Kato M, Nureki O, Hirata Y, Nagai R, Komuro I, Sata M.
    J Am Heart Assoc; 2013 Nov 18; 2(6):e000267. PubMed ID: 24249711
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.